March 2, 2018

March 02, 2018

Advances in the Management of NETs

OncLive – March 1

Jonathan R. Strosberg, MD: It’s great that we have new systemic treatments for this disease. Until recently, there were very few—other than somatostatin analogs. 

Circulator system could be running in USF Tampa area by summer

Tampa Bay Times – March 2

The circulator also aims to be one of the region’s first true examples of a public-private partnership for transit: while Florida Department of Transportation and Hillsborough County have agreed to cover some of the $850,000 price tag, the success of the project is dependent on !P’s anchors, like Moffitt Cancer Center, USF and the James A. Haley Veterans Hospital chipping in, Sharpe said.

NGS Testing Hits Clinical Practice

OncLive – Feb. 19

At Moffitt Cancer Center in Tampa, Florida, pathologists began developing larger panels when it became necessary to test for multiple abnormalities in non–smallcell lung cancer (NSCLC), including EGFR, KRAS, ALK, and ROS1, said Anthony M. Magliocco, MD, FRCPC, FCAP, chair of the Department of Anatomic Pathology at Moffitt.

FHS grad finds the perfect match

The Foxboro Reporter – March 1

McCarthy was moved to Moffitt Cancer Center in Tampa, where she underwent chemotherapy.

“I lived in Moffitt for seven weeks and my dad flew down to Tampa and stayed with me,” she recalled. “I had lots of friends come by so it was a fun time.”

FDA grants Abbvie’s Upadacitinib breakthrough therapy designation for AD

Practical Dermatology – February 2018

Patients with desmoplastic melanoma are more responsive to immune-activating anti-PD-1/PD-L1 therapies than previously assumed, Moffitt Cancer Center researchers report in Nature.

Artificial Intelligence Methods Used for Developing Precision Cancer Medicine

Sanvada – Feb. 28

In projects like these, hurdles often show up in form of data credibility or viability. However, in this case, the researchers will be siphoning their data from Moffitt Cancer Research Center based in the US, Tampa. 

Strosberg Discusses Lutathera Approval, Remaining Challenges in NETs

OncLive – Feb. 28

In an interview during the 2018 OncLive® State of the Science SummitTM on Gastrointestinal Cancers, Jonathan R. Strosberg, MD, an associate professor of Moffitt Cancer Center, discussed ongoing advances and challenges in the treatment of patients with NETs.

GR8 Inspirations: Ice cream entrepreneur on mission to help hospitals following cancer diagnosis

WFLA – Feb. 28

He’s already contacted Moffitt Cancer Center to help with charity events. He’s also announced that Vice Cream is being picked up by Lakeland-based Publix Super Markets.

Cancer Care: A Cure at a Cost

Florida Trend – Feb. 27

“They were without other options, without hope,” says Dr. Frederick Locke, a Moffitt researcher who helped lead the study.

M2Gen’s CEO wants to take personalized cancer treatment to the masses

Florida Trend – Feb. 27

After working more than 30 years in the pharmaceutical and biotech industries, mostly helping to develop anti-cancer drugs, Timothy R. Wright became the CEO of M2Gen last summer. He saw the job, he says, as an opportunity to become a major disruptor.

Cutting-edge care

South Florida Business and Wealth – Feb. 27

Memorial Healthcare Systems has started a partnership with Moffitt Cancer Center, one of the nation’s top treatment facilities. Moffitt Malignant Hematology & Cellular Therapy at MemorialWest in Pembroke Pines offers a comprehensive blood and marrow transplant and cellular therapy program. 

Health Beat: Acupuncture improves cancer treatment

WFMZ – Feb. 27

She started with weekly treatments and continues it now once every three weeks. Dr. Liem Quang Le, an acupuncturist at the H. Lee Moffitt Cancer Center, said it stimulates the body's natural ability to heal itself. Also seen on WINK

A Drink With Major League Baseball Player And Jupiter Resident Logan Morrison

Jupiter Magazine – March 2018

Following the 2013 season, Morrison was traded to the Seattle Mariners where he spent two seasons before signing with the Tampa Bay Rays in 2016. Morrison’s baseball camps for children have raised hundreds of thousands of dollars for organizations such as the American Lung Association and the Moffitt Cancer Center. 

The Not-Fake Media

Florida Trend – Feb. 27

Cancer is the scourge of America, but Floridians are fortunate enough to live in the third-largest state, where we have world-class centers devoted to defeating this disease. For example, researchers at Moffitt Cancer Center in Tampa are using re-engineered T-cells called CAR-T gene therapy to destroy cancer.

One man’s fight to prevent HPV infections

CBS News – Feb. 24

Only 43% of teens take the recommended dose of the HPV vaccine. Dr. John Lapook: “I spoke to Dr. Anna Giuliano who is doing some of the work on this, she said you have to prove that giving the vaccine that protects from head and neck cancer that it also prevents the head and neck cancer. It prevents the virus which can prevent the cancer.”

Sun Safety Tour offers free skin cancer screenings at JetBlue Park

WINK TV – Feb. 25

Residents and visitors of the Sunshine State can stay safe Sunday with free skin cancer screenings during the Sun Safety Tour. Moffitt Cancer Center and the Tampa Bay Rays are doing screenings from 10:30 a.m. to 1 p.m. at JetBlue Park on 11500 Fenway South Drive. 

AAJ Technologies Debuts Alexa Skill for Moffitt Business of Biotech 2018 Conference - Feb. 25

AAJ Technologies ( is a proud sponsor of the Moffitt Cancer Center Business of Biotech Conference in Tampa Florida, Friday 3/2/2018 AAJ Technologies, the conference's Digital Health Sponsor, will display their digital transformation skills by programming 2 Alexa devices located at strategic locations throughout the hall.

The South Florida Hospital War. (It’s all location, location, location)

Miami Herald – Feb. 25

In South Broward, Memorial Cancer Institute has forged a clinical partnership with Moffitt Cancer Center, the well-regarded Tampa-based research organization.

Axicabtagene ciloleucel CAR T-cell therapy shows long-term benefit for non-Hodgkin lymphoma

Healio – Feb. 23

“There is clearly an unmet need in refractory large B-cell lymphoma,” Frederick Locke, MD, interim chair of the department of blood and marrow transplant and cellular immunotherapy program co-leader, immunology of Moffitt Cancer Center, said during his presentation. 


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.